Cargando…
Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?
PURPOSE: To investigate whether elevated glucose metabolism in neurofibroma, determined by [F18]-FDG-PET, is correlated with cell density in MRI, as expressed through the apparent diffusion coefficient. MATERIALS AND METHODS: Patients diagnosed with neurofibromatosis type 1 and peripheral nerve shea...
Autores principales: | Berzaczy, Dominik, Mayerhoefer, Marius E., Azizi, Amedeo A., Haug, Alexander R., Senn, Daniela, Beitzke, Dietrich, Weber, Michael, Traub-Weidinger, Tatjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716584/ https://www.ncbi.nlm.nih.gov/pubmed/29206885 http://dx.doi.org/10.1371/journal.pone.0189093 |
Ejemplares similares
-
Is there a reliable size cut-off for splenic involvement in lymphoma? A [18F]FDG-PET controlled study
por: Berzaczy, Dominik, et al.
Publicado: (2019) -
Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients
por: Berzaczy, Dominik, et al.
Publicado: (2017) -
Ultra-early response assessment in lymphoma treatment: [(18)F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment
por: Mayerhoefer, Marius E., et al.
Publicado: (2018) -
Malignant Peripheral Nerve Sheath Tumor Arising from Neurofibromatosis
por: Lee, Dae-Sung, et al.
Publicado: (2013) -
Malignant Peripheral Nerve Sheath Tumors in Children with Neurofibromatosis Type 1
por: Pourtsidis, Apostolos, et al.
Publicado: (2014)